Back to GetFilings.com




SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

 

        X        

 

QUARTERLY REPORT UNDER SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2005

 

 

 

OR

 

                   

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

For the transition period from ________ to ________

 

 

 

Commission File Number 001-14789

 


GENTEK INC.

(Exact name of registrant as specified in its charter)

 

 Delaware
(State of other jurisdiction of
incorporation or organization)
 02-0505547
(I.R.S. Employer
Identification Number)
 
  
  
 90 East Halsey Road
Parsippany, New Jersey
(Address of principal executive offices)
  
07054
(Zip Code)
 

(973) 515-3221

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes      X          No              

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes      X          No              

APPLICABLE TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE

PRECEEDING FIVE YEARS:

Indicate by checkmark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes      X          No              

The number of outstanding shares of the Registrant’s Common Stock as of May 6, 2005 was 10,088,735.


 

 



GENTEK INC.

FORM 10-Q

QUARTERLY PERIOD ENDED MARCH 31, 2005

INDEX

 

 

Page No.

 

 

PART I.  FINANCIAL INFORMATION:

 

 

 

Item 1.  Financial Statements

 

 

 

Consolidated Statements of Operations – Three Months Ended March 31, 2005 and 2004

1

 

 

Consolidated Balance Sheets – March 31, 2005 and December 31, 2004

2

 

 

Consolidated Statements of Cash Flows – Three Months Ended March 31, 2005 and 2004

3

 

 

Consolidated Statement of Changes in Equity – Three Months Ended March 31, 2005

4

 

 

Notes to the Consolidated Financial Statements

5-12

 

 

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

13-18

 

 

Item 3.  Quantitative and Qualitative Disclosures About Market Risk

19

 

 

Item 4.  Controls and Procedures

19

 

 

 

 

PART II.  OTHER INFORMATION:

 

 

 

Item 1.  Legal Proceedings

20

 

 

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds

20

 

 

Item 3.  Defaults upon Senior Securities

20

 

 

Item 4.  Submission of Matters to a Vote of Security Holders

20

 

 

Item 5.  Other Information

20

 

 

Item 6.  Exhibits

20-23

 

 

SIGNATURES

24



 



PART I. FINANCIAL INFORMATION

Item 1. Financial Statements.

GENTEK INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(unaudited)

  

 

 

Three Months Ended
March 31,

 

 

 


 

 

 

2005

 

2004

 

 

 


 


 

Net revenues

 

$

226,276

 

$

192,930

 

Cost of sales

 

 

198,745

 

 

163,261

 

Selling, general and administrative expense

 

 

20,097

 

 

21,485

 

Restructuring and impairment charges

 

 

4,528

 

 

972

 

Pension curtailment gain

 

 

 

 

14,840

 

 

 



 



 

Operating profit

 

 

2,906

 

 

22,052

 

Interest expense

 

 

5,148

 

 

4,439

 

Interest income

 

 

114

 

 

84

 

Other (income) expense, net

 

 

281

 

 

(1,634

)

 

 



 



 

Income (loss) from continuing operations before income taxes

 

 

(2,409

)

 

19,331

 

Income tax provision (benefit)

 

 

(1,382

)

 

8,340

 

 

 



 



 

Income (loss) from continuing operations

 

 

(1,027

)

 

10,991

 

Income from discontinued operations (net of tax of $2,434 for
the three months ended March 31, 2004)

 

 

 

 

3,814

 

 

 



 



 

Net income (loss)

 

$

(1,027

)

$

14,805

 

 

 



 



 

Income (loss) per common share – basic:

 

 

 

 

 

 

 

Income (loss) from continuing operations

 

$

(0.10

)

$

1.10

 

Income from discontinued operations

 

 

 

 

.38

 

 

 



 



 

Net income (loss)

 

$

(0.10

)

$

1.48

 

 

 



 



 

Income (loss) per common share – assuming dilution:

 

 

 

 

 

 

 

Income (loss) from continuing operations

 

$

(0.10

)

$

1.10

 

Income from discontinued operations

 

 

 

 

.38

 

 

 



 



 

Net income (loss)

 

$

(0.10

)

$

1.48

 

 

 



 



 


See the accompanying notes to the consolidated financial statements.

 

 

-1-

 



GENTEK INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

(unaudited)

 

 

 

March 31,
2005

 

December 31,
2004

 

 

 


 


 

ASSETS

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

9,882

 

$

9,826

 

Receivables, net

 

 

134,612

 

 

117,636

 

Inventories

 

 

79,506

 

 

76,174

 

Deferred income taxes

 

 

12,502

 

 

14,225

 

Other current assets

 

 

7,565

 

 

7,369

 

 

 



 



 

Total current assets

 

 

244,067

 

 

225,230

 

Property, plant and equipment, net

 

 

283,496

 

 

284,957

 

Goodwill

 

 

154,354

 

 

154,365

 

Intangible assets

 

 

68,874

 

 

70,532

 

Deferred income taxes

 

 

2,816

 

 

3,737

 

Other assets

 

 

17,480

 

 

14,805

 

 

 



 



 

Total assets

 

$

771,087

 

$

753,626

 

 

 



 



 

LIABILITIES AND EQUITY

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Accounts payable

 

$

59,206

 

$

55,294

 

Accrued liabilities

 

 

62,436

 

 

71,562

 

Current portion of long-term debt

 

 

4,175

 

 

1,489

 

 

 



 



 

Total current liabilities

 

 

125,817

 

 

128,345

 

Long-term debt

 

 

384,812

 

 

11,047

 

Pension and postretirement obligations

 

 

106,669

 

 

142,758

 

Other liabilities

 

 

67,061

 

 

71,049

 

 

 



 



 

Total liabilities

 

 

684,359

 

 

353,199

 

 

 



 



 

Equity:

 

 

 

 

 

 

 

Preferred Stock, $.01 par value; authorized: 10,000,000 shares; none issued or outstanding

 

 

 

 

 

Common Stock, no par value; authorized: 100,000,000 shares; issued: 10,091,947 and 10,098,570 shares at March 31, 2005 and December 31, 2004, respectively

 

 

80,534

 

 

271,690

 

Unearned compensation

 

 

(1,444

)

 

(2,123

)

Warrants

 

 

8,361

 

 

8,361

 

Accumulated other comprehensive loss

 

 

(929

)

 

(886

)

Retained earnings

 

 

220

 

 

123,385

 

Treasury stock, at cost: 765 shares at March 31, 2005

 

 

(14

)

 

 

 

 



 



 

Total equity

 

 

86,728

 

 

400,427

 

 

 



 



 

Total liabilities and equity

 

$

771,087

 

$

753,626

 

 

 



 



 


See the accompanying notes to the consolidated financial statements.

 

 

-2-

 



GENTEK INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(unaudited)

 

 

 

Three Months Ended
March 31,

 

 

 


 

 

 

2005

 

2004

 

 

 


 


 

Cash flows from operating activities:

 

 

 

 

 

 

 

Net income (loss) from continuing operations

 

$

(1,027

)

$

10,991

 

Adjustments to reconcile net income (loss) to net cash used for operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

 

11,012

 

 

10,145

 

Pension curtailment gain

 

 

 

 

(14,840

)

Net loss (gain) on disposition of long-term assets

 

 

9

 

 

(2,968

)

Long-term incentive plan costs, net

 

 

440

 

 

 

Increase in receivables

 

 

(17,160

)

 

(12,928

)

Increase in inventories

 

 

(3,357

)

 

(428

)

Decrease in deferred tax assets

 

 

2,604

 

 

6,937

 

Increase in accounts payable

 

 

4,088

 

 

5,221

 

Decrease in accrued liabilities

 

 

(11,794

)

 

(4,304

)

Decrease in other liabilities and assets, net

 

 

(32,373

)

 

(15,785

)

 

 



 



 

Net cash used for continuing operations

 

 

(47,558

)

 

(17,959

)

Net cash used for discontinued operations

 

 

 

 

(243

)

 

 



 



 

Net cash used for operating activities

 

 

(47,558

)

 

(18,202

)

 

 



 



 

Cash flows from investing activities:

 

 

 

 

 

 

 

Capital expenditures

 

 

(7,779

)

 

(5,361

)

Proceeds from sales or disposals of long-term assets

 

 

57

 

 

3,113

 

Other investing activities

 

 

 

 

(45

)

 

 



 



 

Net cash used for investing activities

 

 

(7,722

)

 

(2,293

)

 

 



 



 

Cash flows from financing activities:

 

 

 

 

 

 

 

Proceeds from long-term debt

 

 

401,354

 

 

12,989

 

Repayment of long-term debt

 

 

(35,556

)

 

(27

)

Dividends

 

 

(310,334

)

 

 

Acquisition of treasury stock

 

 

(14

)

 

 

 

 



 



 

Net cash provided by financing activities

 

 

55,450

 

 

12,962

 

 

 



 



 

Effect of exchange rate changes on cash

 

 

(114

)

 

(47

)

 

 



 



 

Increase (decrease) in cash and cash equivalents

 

 

56

 

 

(7,580

)

Cash and cash equivalents at beginning of period

 

 

9,826

 

 

26,646

 

 

 



 



 

Cash and cash equivalents at end of period

 

$

9,882

 

$

19,066

 

 

 



 



 

Supplemental information:

 

 

 

 

 

 

 

Cash paid for income taxes

 

$

1,842

 

$

1,335

 

 

 



 



 

Cash paid for interest

 

$

824

 

$

4,272

 

 

 



 



 

See the accompanying notes to the consolidated financial statements.

 

 

-3-

 



GENTEK INC.

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

For the Three Months Ended March 31, 2005

(In thousands, except per share data)

 

 

 

Common
Stock

 

Unearned
Compensation

 

Warrants

 

Treasury
Stock

 

Accumulated
Other
Comprehensive
Income
(Loss)

 

Retained
Earnings

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2004

 

$

271,690

 

$

(2,123

)

$

8,361

 

$

 

$

(886

)

$

123,385

 

$

400,427

 

Components of comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

(1,027

)

 

(1,027

)

Foreign currency translation adjustments (net of tax of $(49))

 

 

 

 

 

 

 

 

 

 

(75

)

 

 

 

(75

)

Change in unrealized gain on derivative instruments (net of tax of $21)

 

 

 

 

 

 

 

 

 

 

32

 

 

 

 

32

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

Comprehensive income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,070

)

Long-term incentive plan, net

 

 

(239

)

 

679

 

 

 

 

 

 

 

 

 

 

440

 

Dividends ($31.00 per share)

 

 

(190,917

)

 

 

 

 

 

 

 

 

 

(122,138

)

 

(313,055

)

Purchase of treasury stock

 

 

 

 

 

 

 

 

(14

)

 

 

 

 

 

(14

)

 

 



 



 



 



 



 



 



 

Balance at March 31, 2005

 

$

80,534

 

$

(1,444

)

$

8,361

 

$

(14

)

$

(929

)

$

220

 

$

86,728

 

 

 



 



 



 



 



 



 



 

See the accompanying notes to the consolidated financial statements.

 

 

-4-

 



GENTEK INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except per share data)

(unaudited)

Note 1 – Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2005 are not indicative of the results that may be expected for the year ending December 31, 2005. These statements should be read in conjunction with the financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2004.

On May 18, 2004, the Company sold its KRONE communications business to ADC Telecommunications, Inc. and recognized a gain of $185,044. Accordingly, the business has been classified as discontinued operations. See Note 11.

On June 30, 2004, the Company acquired a wire harness and subassembly manufacturing facility located in Reynosa, Mexico from Whirlpool Corporation for $8,400. As part of the transaction, the Company entered into a seven-year supply agreement to supply wire harnesses, panel assemblies, copper tubing and related components to Whirlpool’s North American appliance production facilities. The results of operations of the facility have been included in the financial statements beginning July 1, 2004. The pro forma impact of the acquisition on financial position, net income and earnings per share is not material. Revenues from the supply agreement were $41,889 for the three-month period ended March 31, 2005.

On December 27, 2004, the Company paid a special dividend of $7.00 per common share, totaling approximately $70,690, which was funded primarily from excess cash generated from the sale of the Company’s KRONE communications business.

On February 28, 2005, the Company’s board of directors declared a special dividend of $31.00 per common share which was paid on March 16, 2005. Also, on February 28, 2005, GenTek closed on a secured financing consisting of $370,000 of term loans and a $60,000 revolving credit facility. In connection with the closing of the new financing, the Company recorded a charge in interest expense of $3,030 to write-off deferred financing costs of its then-existing debt facility which was terminated.

Note 2 – Summary of Significant Accounting Policies

Compensation cost for stock-based employee compensation plans is recognized using the intrinsic value method. The following table illustrates the effect on net income (loss) and net income (loss) per share if the Company had applied the fair value based method to recognize stock-based employee compensation.

 

 

-5-

 



GENTEK INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in thousands, except per share data)

(unaudited)

 

 

 

Three Months Ended
March 31,

 

 

 


 

 

 

2005

 

2004

 

 

 


 


 

Net income (loss) as reported

 

$

(1,027

)

$

14,805

 

Deduct: Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects

 

 

(65

)

 

 

 

 



 



 

Pro forma net income (loss)

 

$

(1,092

)

$

14,805

 

 

 



 



 

Income (loss) per share:

 

 

 

 

 

 

 

Basic – as reported

 

$

(0.10

)

$

1.48

 

 

 



 



 

Basic – pro forma

 

$

(0.11

)

$

1.48

 

 

 



 



 

Diluted – as reported

 

$

(0.10

)

$

1.48

 

 

 



 



 

Diluted – pro forma

 

$

(0.11

)

$

1.48

 

 

 



 



 

                                                                                                                                                

For purposes of this calculation, the fair value of each option grant was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions (not applicable for 2005 as there were no grants made):

 

 

 

2004

 

 

 


 

Dividend yield

 

 

 

Expected volatility

 

 

50

%

Risk-free interest rate

 

 

2.32

%

Expected holding period (in years)

 

 

4

 

Weighted average fair value

 

$

14.82

 

Certain prior-period amounts have been reclassified to conform with the current presentation.

In December 2004, the FASB issued SFAS No. 123R, “Share-Based Payment (Revised 2004).” This statement addresses the accounting for share-based payment transactions in which a company receives employee services in exchange for the company’s equity instruments or liabilities that are based on the fair value of the company’s equity securities or may be settled by the issuance of these securities. SFAS No. 123R eliminates the ability to account for share-based compensation using the intrinsic value method and generally requires that such transactions be accounted for using a fair value method. In April 2005, the Securities and Exchange Commission adopted a final rule amending the effective date. The provisions of this statement are effective for financial statements issued for the first interim period of the first fiscal year beginning after June 15, 2005. The Company has yet to determine a transition method to adopt SFAS 123R or which valuation method to use. The full impact that the adoption of this statement will have on the Company’s financial statements will be determined by share-based payments granted in future periods, the transition method and valuation model used.

Note 3 – Comprehensive Income (Loss)

Total comprehensive income (loss) is comprised of net income (loss), foreign currency translation adjustments and the change in unrealized gains and losses on derivative financial instruments. Total comprehensive income (loss) for the three months ended March 31, 2005 and 2004 was $1,070 and $15,216, respectively.

 

 

-6-

 



GENTEK INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in thousands, except per share data)

(unaudited)

Note 4 – Earnings Per Share

The computation of basic earnings per share is based on the weighted average number of common shares outstanding during the period. The computation of diluted earnings per share assumes the foregoing and, in addition, the exercise of all warrants, stock options and restricted stock, using the treasury stock method.

The shares outstanding used for basic and diluted earnings per common share are reconciled as follows:

 

 

 

Three Months Ended
March 31,

 

 

 


 

 

 

2005

 

2004

 

 

 


 


 

Basic earnings per common share:

 

 

 

 

 

Weighted average common shares outstanding

 

10,000,364

 

10,000,000

 

 

 


 


 

Diluted earnings per common share:

 

 

 

 

 

Weighted average common shares outstanding

 

10,000,364

 

10,000,000

 

Warrants, options and restricted stock

 

 

 

 

 


 


 

Total

 

10,000,364

 

10,000,000

 

 

 


 


 

For the three months ended March 31, 2005 and 2004, potentially dilutive securities totaling 3,188,000 and 2,094,645, respectively, were not included in the computation of diluted earnings per common share due to their antidilutive effect.

Note 5 – Additional Financial Information

Cash and cash equivalents

Included in cash and cash equivalents at March 31, 2005 is a deposit of $2,729 made by the Company that the Company intends to restrict the use of only for the purpose of paying dividends previously declared on restricted stock issued to directors and certain executives. Payments are expected to be made through March 2006 subject to vesting requirements.

 

 

 

March 31,
2005

 

December 31,
2004

 

 

 


 


 

Inventories

 

 

 

 

 

 

 

Raw materials

 

$

31,481

 

$

32,394

 

Work in process

 

 

10,226

 

 

9,630

 

Finished products

 

 

36,706

 

 

32,493

 

Supplies and containers

 

 

1,093

 

 

1,657

 

 

 



 



 

 

 

$

79,506

 

$

76,174

 

 

 



 



 

 

-7-

 



GENTEK INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in thousands, except per share data)

(unaudited)

 

Note 6 – Long-Term Debt

 

 

 

Maturities

 

March 31,
2005

 

December 31,
2004

 

 

 


 


 


 

$60,000 revolving credit facility – floating rates

 

2010

 

$

14,000

 

$

 

First lien term loan – floating rates

 

2011

 

 

235,000

 

 

 

Second lien term loan – floating rates

 

2012

 

 

135,000

 

 

 

$125,000 revolving credit facility – floating rates

 

2008

 

 

 

 

6,500

 

Other debt – various

 

2005-2018

 

 

4,987

 

 

6,036

 

 

 

 

 



 



 

Total debt

 

 

 

 

388,987

 

 

12,536

 

Less: Current portion

 

 

 

 

4,175

 

 

1,489

 

 

 

 

 



 



 

Net long-term debt

 

 

 

$

384,812

 

$

11,047

 

 

 

 

 



 



 

On February 28, 2005, the Company closed on a secured financing consisting of $370,000 of term loans and a $60,000 revolving credit facility (the “Credit Facilities”). The term loans include a $235,000 first lien loan due in March 2011 with an interest rate of LIBOR plus 2.75 percent or base rate plus 1.75 percent, subject to a rate reduction of 0.25 percent if such term loan is rated B1 or better by Moody’s Investor Services, Inc. and a $135,000 second lien loan due March 2012 with an interest rate of LIBOR plus 5.75 percent or base rate plus 4.75 percent. The $60,000 revolving credit facility matures in March 2010 and carries an interest rate of LIBOR plus 2.75 percent or base rate plus 1.75 percent, subject to rate reductions under a pricing grid if the Company’s leverage ratio decreases. The first lien term loan is subject to amortization of $2,350 per year for five years, with the remainder payable over the sixth year. There is no amortization over the term of the second lien loan. The Credit Facilities are secured by liens on substantially all of the personal property and certain real property of the Company and its domestic subsidiaries. The Credit Facilities contain covenants which impose certain restrictions on the Company’s ability to, among other things, incur additional debt, pay dividends, make investments or sell assets. A portion of excess cash flow, as defined in the Credit Facilities, and certain non-recurring cash inflows such as proceeds from asset sales, insurance recoveries, and equity offerings must be used to pay down indebtedness and may not be reborrowed. In addition, the Credit Facilities contain certain financial covenants which include a maximum leverage ratio, minimum interest coverage ratio and maximum annual capital expenditures.

In conjunction with securing the Credit Facilities, all amounts outstanding under the Company’s $125,000 revolving credit facility were repaid and the underlying credit agreement was terminated.

Note 7 – Capital Stock

The Company has the following warrants outstanding:

 

 

 

 

 

March 31, 2005

 

December 31, 2004

 

 

 

 


 


 

 

Expiration Date

 

Number of
shares covered

 

Exercise Price

 

Number of
shares covered

 

Exercise Price

 

 

 


 


 


 


 


 

Tranche B

 

November 10, 2008

 

1,998,129

 

$

19.98

 

717,531

 

$

55.65

 

Tranche C

 

November 10, 2010

 

975,886

 

$

22.03

 

350,442

 

$

61.35

 

The terms of the warrants provide for the number of shares covered by the warrants and the exercise prices to be adjusted in the case of certain events, including dividends. During March, 2005, the Company paid a special dividend of $31.00 per share, and the number of shares covered by the warrants and their exercise prices were adjusted pursuant their terms.

 

 

-8-

 



GENTEK INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in thousands, except per share data)

(unaudited)

Note 8 – Segment Information

The Company has changed the name of the former “performance products” segment to “performance chemicals,” to more appropriately describe this segment’s business. Industry segment information is summarized as follows:

 

 

 

Three Months Ended
March 31,

 

 

 


 

 

 

2005

 

2004

 

 

 


 


 

Net Revenues

 

 

 

 

 

 

 

Manufacturing

 

$

146,800

 

$

113,977

 

Performance chemicals

 

 

76,169

 

 

75,505

 

Corporate and other

 

 

3,307

 

 

3,448

 

 

 



 



 

Consolidated

 

$

226,276

 

$

192,930

 

 

 



 



 


 

 

Three Months Ended
March 31,

 

 

 


 

 

 

2005

 

2004 (1)

 

 

 


 


 

Operating Profit (Loss)

 

 

 

 

 

 

 

Manufacturing

 

$

2,292

 

$

11,131

 

Performance chemicals

 

 

5,016

 

 

11,759

 

Corporate and other

 

 

(4,402

)

 

(838

)

 

 



 



 

Consolidated

 

 

2,906

 

 

22,052

 

Interest expense

 

 

5,148

 

 

4,439

 

Other (income) expense, net

 

 

167

 

 

(1,718

)

 

 



 



 

Consolidated income (loss) from continuing operations before income taxes

 

$

(2,409

)

$

19,331

 

 

 



 



 


(1)

Includes pension curtailment gains of $1,685 in the manufacturing segment, $11,656 in the performance chemicals segment, and $1,499 in corporate and other.

 

 

Three Months Ended
March 31,

 

 

 


 

 

 

2005

 

2004

 

 

 


 


 

Capital Expenditures

 

 

 

 

 

 

 

Manufacturing

 

$

3,353

 

$

1,585

 

Performance chemicals

 

 

4,426

 

 

3,611

 

Corporate and other

 

 

 

 

165

 

 

 



 



 

Consolidated

 

$

7,779

 

$

5,361

 

 

 



 



 


 

 

 

Three Months Ended
March 31,

 

 

 


 

 

 

2005

 

2004

 

 

 


 


 

Depreciation and Amortization

 

 

 

 

 

 

 

Manufacturing

 

$

6,518

 

$

5,887

 

Performance chemicals

 

 

4,159

 

 

3,990

 

Corporate and other

 

 

335

 

 

268

 

 

 



 



 

Consolidated

 

$

11,012

 

$

10,145

 

 

 



 



 



 

-9-

 



GENTEK INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in thousands, except per share data)

(unaudited)

 

 

 

March 31, 2005

 

December 31, 2004

 

 

 


 


 

Identifiable Assets

 

 

 

 

 

 

 

Manufacturing

 

$

463,922

 

$

453,906

 

Performance chemicals(1)

 

 

273,954

 

 

275,155

 

Corporate and other

 

 

33,211

 

 

24,565

 

 

 



 



 

Consolidated

 

$

771,087

 

$

753,626

 

 

 



 



 


(1)

Includes equity method investments of $354 and $339, respectively.

Note 9 – Restructuring and Impairment Charges

During the first quarter of 2005, the Company initiated actions to close one facility in its manufacturing segment and one facility included in corporate and other businesses. In addition, the Company initiated a workforce reduction affecting corporate employees. During 2004, the Company initiated actions to close one facility in its manufacturing segment and two facilities in its performance chemicals segment. In addition, the Company initiated a workforce reduction affecting its corporate and other businesses. The Company expects to substantially complete implementation of these restructuring actions by the end of 2005. The following tables summarize the Company’s expected costs and accruals for these restructuring actions:

 

 

 

Manufacturing

 

Performance
Chemicals

 

Corporate
& Other

 

Total

 

 

 


 


 


 


 

Employee Termination Costs

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs incurred in prior periods

 

$

1,265

 

$

8,365

 

$

350

 

$

9,980

 

Costs incurred in current period

 

 

374

 

 

106

 

 

2,761

 

 

3,241

 

Costs anticipated to be incurred in the future

 

 

77

 

 

 

 

594

 

 

671

 

 

 



 



 



 



 

Total costs expected to be incurred

 

$

1,716

 

$

8,471

 

$

3,705

 

$

13,892

 

 

 



 



 



 



 

Accrual balance at December 31, 2004

 

$

207

 

$

944

 

$

277

 

$

1,428

 

Provisions

 

 

374

 

 

106

 

 

2,761

 

 

3,241

 

Amounts paid

 

 

(261

)

 

(538

)

 

(402

)

 

(1,201

)

 

 



 



 



 



 

Accrual balance at March 31, 2005

 

$

320

 

$

512

 

$

2,636

 

$

3,468

 

 

 



 



 



 



 


 

 

Manufacturing

 

Performance
Chemicals

 

Corporate
& Other

 

Total

 

 

 


 


 


 


 

Facility Exit Costs

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs incurred in prior periods

 

$

430

 

$

14,253

 

$

 

$

14,683

 

Costs incurred in current period

 

 

481

 

 

677

 

 

129

 

 

1,287

 

Costs anticipated to be incurred in the future

 

 

451

 

 

500

 

 

681

 

 

1,632

 

 

 



 



 



 



 

Total costs expected to be incurred

 

$

1,362

 

$

15,430

 

$

810

 

$

17,602

 

 

 



 



 



 



 

Accrual balance at December 31, 2004

 

$

 

$

843

 

$

 

$

843

 

Provisions

 

 

481

 

 

677

 

 

129

 

 

1,287

 

Amounts paid

 

 

(481

)

 

(1,481

)

 

(129

)

 

(2,091

)

 

 



 



 



 



 

Accrual balance at March 31, 2005

 

$

 

$

39

 

$

 

$

39

 

 

 



 



 



 



 



 

-10-

 



GENTEK INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in thousands, except per share data)

(unaudited)

Note 10 – Pension and Other Postretirement Benefits

 

 

 

Three Months Ended
March 31,

 

 

 


 

 

 

2005

 

2004

 

 

 


 


 

Pension Benefits

 

 

 

 

 

 

 

Service cost

 

$

400

 

$

1,375

 

Interest cost

 

 

3,190

 

 

3,501

 

Expected return on plan assets

 

 

(3,452

)

 

(2,755

)

Amortization of net:

 

 

 

 

 

 

 

Prior service cost

 

 

19

 

 

 

 

 



 



 

Net periodic benefit cost

 

$

157

 

$

2,121

 

 

 



 



 


 

 

Three Months Ended
March 31,

 

 

 


 

 

 

2005

 

2004

 

 

 


 


 

Other Postretirement Benefits

 

 

 

 

 

 

 

Service cost

 

$

263

 

$

364

 

Interest cost

 

 

707

 

 

1,091

 

Expected return on plan assets

 

 

 

 

 

Amortization of net:

 

 

 

 

 

 

 

Prior service cost

 

 

(683

)

 

 

Gain

 

 

(37

)

 

 

 

 



 



 

Net periodic benefit cost

 

$

250

 

$

1,455

 

 

 



 



 


During the first quarter of 2004, the Company notified its employees that benefit accruals in defined benefit pension plans covering domestic salaried and certain hourly employees would be frozen effective April 1, 2004. This action resulted in a curtailment gain of $14,840. During the second quarter of 2004, the Company accrued $1,130 of contractual termination pension benefits, related to the closure of a plant, which was recorded as a component of restructuring and impairment charges.

During the first quarter of 2005, the Company contributed $35,804 to its pension plan trusts and expects to make additional contributions to foreign pension plans of approximately $1,200 during the remainder of 2005.

Note 11 – Discontinued Operations

On March 25, 2004, the Company signed a definitive agreement to sell its KRONE communications business. The transaction was completed on May 18, 2004, and resulted in a gain of $185,044, net of a tax provision of $81,115 of which $5,560 represents the current or cash portion and $75,555 represents the deferred portion. The net gain is included in income from discontinued operations.

 

 

-11-

 



GENTEK INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Concluded)

(Dollars in thousands, except per share data)

(unaudited)

The businesses included in discontinued operations had revenues of $83,896 and pretax profit of $6,248 for the three months ended March 31, 2004. The businesses were formerly reported as part of the communications segment, which is no longer a reportable segment as a result of the reclassification of this business to discontinued operations.

 

 

-12-

 



Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

This Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The Company’s actual results could differ materially from those set forth in the forward-looking statements. Certain factors that might cause such a difference include those discussed in the section entitled, “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Forward-Looking Statements” contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2004.

During the first quarter of 2004, the Company notified its employees that benefit accruals in defined benefit pension plans covering domestic salaried and certain hourly employees would be frozen effective April 1, 2004. As a result, a curtailment gain of approximately $15 million was recognized during the first quarter of 2004.

On May 18, 2004 the Company sold its KRONE communications business to ADC Telecommunications, Inc. Accordingly, all financial information included herein has been reclassified to reflect the KRONE communications business as discontinued operations. Net proceeds from the transaction of approximately $291 million were used to repay the Company’s then-outstanding Senior Term Loan Agreement in full, and the related loan agreement was terminated. Consummation of this transaction triggered the contingent redemption feature of the Company’s tranche A warrants. The Company made the required payment of $8.4 million ($7.13 per warrant) on June 30, 2004, and the tranche A warrants expired.

On June 30, 2004, the Company acquired a wire harness and subassembly manufacturing facility located in Reynosa, Mexico from Whirlpool Corporation for $8.4 million. As part of the transaction, the Company entered into a seven-year supply agreement to supply wire harnesses, panel assemblies, copper tubing and related components to Whirlpool’s North American appliance production facilities. The results of operations of the facility have been included in the financial statements beginning July 1, 2004. Revenues from the supply agreement were $42 million for the three-month period ended March 31, 2005.

On December 27, 2004, the Company paid a special dividend of $7.00 per common share, totaling approximately $71 million, which was funded primarily from excess cash generated from the sale of the Company’s KRONE communications business.

On February 28, 2005, the Company’s board of directors declared a special dividend of $31.00 per common share which was paid on March 16, 2005. Also, on February 28, 2005, GenTek closed on a secured financing consisting of $370 million of term loans and a $60 million revolving credit facility. The Company used approximately $310 million, which is net of $3 million of dividends remaining to be paid, of the financing proceeds to pay the special dividend and $35 million of the proceeds to pre-fund certain defined benefit pension obligations. The remainder of the proceeds were used to pay transaction fees, to refinance existing debt and for general corporate purposes. In connection with the closing of the new financing, the Company recorded a charge in interest expense of approximately $3 million to write-off deferred financing costs of its then-existing debt facility. The payment of the two special dividends and the closing on the financing reflect the completion of a recapitalization of the Company. The two dividends provided substantial value to holders of the Company’s common stock. In addition, the Company believes these actions established a more appropriate capital structure for GenTek that allows the Company to continue to invest in its core businesses. Prior to the recapitalization, the Company’s balance sheet was substantially debt-free. By leveraging the Company, GenTek believes it has better positioned the Company to realize increased returns for its shareholders.

 

 

-13-

 



Results of Operations

The following table sets forth certain line items from our Consolidated Statements of Operations for the three months ended March 31, 2005 and 2004 and the corresponding percentage of net revenues for the relevant periods presented as a percentage of revenue for the periods indicated.

 

 

 

Three Months Ended
March 31,

 

 

 


 

 

 

2005

 

2004

 

 

 


 


 

 

 

(Dollars in millions)

 

Net revenues

 

$

226.2

 

100

%

$

192.9

 

100

%

Cost of sales

 

 

198.7

 

88

 

 

163.2

 

85

 

Selling, general and administrative expense

 

 

20.1

 

9

 

 

21.5

 

11

 

Restructuring and impairment charges

 

 

4.5

 

2

 

 

0.9

 

 

Pension curtailment gain

 

 

 

 

 

14.8

 

7

 

 

 



 


 



 


 

Operating profit (loss)

 

 

2.9

 

1

 

 

22.1

 

11

 

Interest expense

 

 

5.1

 

2

 

 

4.5

 

2

 

Interest income

 

 

0.1

 

 

 

0.1

 

 

Reorganization items

 

 

 

 

 

 

 

Other (income) expense, net

 

 

0.3

 

 

 

(1.6

)

(1

)

Income tax provision (benefit)

 

 

(1.4

)

(1

)

 

8.3

 

4

 

 

 



 


 



 


 

Income (loss) from continuing operations

 

 

(1.0

)

 

 

11.0

 

6

 

Income from discontinued operations

 

 

 

 

 

3.8

 

2

 

 

 



 


 



 


 

Net income

 

$

(1.0

)

%

$

14.8

 

8

%

 

 



 


 



 


 

Three Months Ended March 31, 2005 Compared with Three Months Ended March 31, 2004

Net revenues were $226 million for the three-month period ended March 31, 2005 compared with $193 million for the prior year. This increase is due primarily to higher sales in the manufacturing segment as the result of higher sales in the appliance and electronics market of $37 million, partially offset by lower sales volume in the Company’s North American automotive customer base of $4 million. The increase in revenues in the appliance and electronics market was principally driven by the acquisition of a wire harness and subassembly manufacturing facility from Whirlpool Corporation on June 30, 2004. The decrease in revenues in the automotive market reflects the impact of lower sales volumes.

Gross profit was $28 million for the three-month period ended March 31, 2005 as compared with $30 million for the prior year. This decrease is principally due to lower gross profit in the manufacturing segment of $4 million, partially offset by higher gross profit in the performance chemicals segment of $3 million. In the manufacturing segment, lower gross profits were due the impact of lower automotive volumes and higher raw material costs. Gross profit as a percentage of sales decreased because of the preceding factors along with the incremental revenues related to the Whirlpool transaction generating significantly lower gross profit margins than other existing business. The increase in performance chemicals gross profit is principally due to the impact of the pass through of previously incurred higher raw material costs in the water chemical product line, lower plant spending in the sulfur products business, and plant cost savings net of lost revenue of $1 million due to the closure of the Company’s Delaware Valley Works North Plant.

 

 

-14-

 



Selling, general and administrative expense was $20 million for the three-month period ended March 31, 2005, compared to $21 million in the prior year. This decrease is primarily attributable to lower pension and other post-retirement benefits expense as well as headcount reductions.

Restructuring and impairment charges were $5 million for the three-month period ended March 31, 2005 as compared with $1 million being recorded during the first quarter of 2004. The charges recorded in 2005 are associated with the closure of two production facilities, a headcount reduction and continuing costs from activities initiated during 2004.

During the first quarter of 2004, the Company notified its employees that benefit accruals in defined benefit pension plans covering domestic salaried and certain hourly employees would be frozen effective April 1, 2004. As a result, a curtailment gain of approximately $15 million was recognized during the first quarter of 2004.

Operating income was $3 million for the three-month period ended March 31, 2005 as compared with an operating income of $22 million for the prior year. This decrease was principally due to impact of the abovementioned pension curtailment gain and the higher restructuring charges recorded during the first quarter of 2005.

Interest expense was $5 million for the three-month period ended March 31, 2005, which includes a charge of $3 million to write-off deferred financing costs for debt retired during the period.

Included in other (income)/expense, net for the three-month period ended March 31, 2004 is a gain of $3 million from the sale of the Company’s minority interest in its joint venture with Esseco S.P.A.

Income from discontinued operations was $4 million for the three-month period ended March 31, 2004, reflecting the impact of the KRONE communications business, which was sold on May 18, 2004.

Results of Operations by Segment

 

 

 

 

Three Months Ended
March 31,

 

 

 


 

 

 

2005

 

2004

 

   
 
 

Net Revenues

 

(In millions)

 

Manufacturing

 

$

146.8

 

$

114.0

 

Performance chemicals

 

 

76.2

 

 

75.5

 

Corporate and other

 

 

3.3

 

 

3.4

 

 

 



 



 

Total

 

$

226.3

 

$

192.9

 

 

 



 



 

 

 

 

Three Months Ended
March 31,

 

 

 


 

 

 

2005 (1)

 

2004 (2)

 

   
 
 

Operating Profit (Loss)

 

(In millions)

 

Manufacturing

 

$

2.3

 

$

11.1

 

Performance chemicals

 

 

5.0

 

 

11.8

 

Corporate and other

 

 

(4.4

)

 

(0.8

)

 

 



 



 

Total

 

$

2.9

 

$

22.1

 

 

 



 



 

(1)

Includes restructuring and impairment charges of $0.9 million in the manufacturing segment, $0.8 million in the performance chemicals segment and $2.8 million in corporate and other.

 

 

-15-

 



(2)

Includes restructuring and impairment charges of $1.0 in the performance chemicals segment. Also includes pension curtailment gains of $1.7 in the manufacturing segment, $11.7 in the performance chemicals segment and $1.5 in corporate and other.

Three Months Ended March 31, 2005 Compared with Three Months Ended March 31, 2004

Manufacturing Segment

Net revenues for the manufacturing segment were $147 million for the three-month period ended March 31, 2005 as compared to $114 million for the comparable prior-year period. This increase is principally due to higher sales in the appliance and electronics market of $37 million, partially offset by lower sales volume in the Company’s North American automotive customer base of $4 million. The increase in revenues in the appliance and electronics market was principally driven by the acquisition of a wire harness and subassembly manufacturing facility from Whirlpool Corporation on June 30, 2004. The decrease in revenues in the automotive market reflects the impact of lower sales volumes. Gross profit was $15 million for the three-month period ended March 31, 2005, compared to $19 million for the comparable prior year period due to the impact of lower automotive volumes and higher raw material costs. Gross profit as a percentage of sales decreased because of the preceding factors along with the incremental revenues related to the Whirlpool transaction generating significantly lower gross profit margins than other existing business. Selling, general and administrative expense was $12 million for the three-month period ended March 31, 2005 compared to $10 million for the comparable prior-year period principally due to higher allocated corporate expenses due to the sale of the communications business and the acquisition of a wire harness and subassembly manufacturing facility. Operating income for the three-month period ended March 31, 2005 was $2 million as compared to $11 million for the prior-year period. This decrease is principally due to the lower gross profit and higher selling, general and administrative expense described above and a $2 million pension curtailment gain in 2004.

Performance Chemicals Segment

Net revenues for the performance chemicals segment were $76 million for the three-month period ended March 31, 2005, essentially level with revenues for the comparable prior-year period. Higher sales in the water chemical and personal care product lines of $3 million and $1 million, respectively, were substantially offset by lower sales in the Company’s fine chemical product line of $3 million. The decrease in revenues in the fine chemicals product line reflects the impact of shutdown of the Company’s Delaware Valley Works North Plant in January 2005 and the impact of the restructuring of the sulfur derivatives business in 2004. Gross profit was $13 million for the three-month period ended March 31, 2005 as compared to $10 million for the prior-year period. The increase in gross profit is principally due to the impact of the pass through of previously incurred higher raw material costs in the water chemical product line, lower plant spending in the sulfur products business, and cost savings net of lost revenue of $1 million due to the closure of the Delaware Valley Works North Plant. Selling, general and administrative expense was $8 million for the three-month period ended March 31, 2005, compared with $9 million during the prior year period. This decrease was principally due to lower pension and other post-retirement benefits costs as well as headcount reductions partially offset by higher allocated corporate expenses due to the sale of the communications business. Restructuring and impairment charges were $1 million for the three-month period ended March 31, 2005, which approximated the prior-year level. Operating income was $5 million for the three-month period ended March 31, 2005 as compared to $12 million for the prior year period. This decrease is principally due to a $12 million pension curtailment gain recorded in 2004, partially offset by the above-mentioned higher gross profit and lower selling, general and administrative expense.

 

 

-16-

 



Corporate and Other

Net revenues, which reflect sales of the Company’s printing plate product line, were substantially unchanged for the quarter. The increase in the operating loss reflects $3 million of restructuring charges incurred with respect to the Company’s plan to exit the printing plate business and for a corporate headcount reduction, the effect of a $1 million pension curtailment gain in 2004 offset by lower corporate spending of $1 million.

Financial Condition, Liquidity and Capital Resources

Cash and cash equivalents were $10 million at March 31, 2005, unchanged from December 31, 2004. Significant cash flows during the period included cash used by operating activities of $48 million, capital expenditures of $8 million, dividend payments of $310 million, offset by borrowings of $366 million. Cash used for operating activities includes contributions made to pension plans of $36 million.

The Company had working capital of $118 million at March 31, 2005 as compared with working capital of $97 million at December 31, 2004. This increase in working capital principally reflects higher accounts receivable balances and inventories and lower accrued liabilities partially offset by higher accounts payable principally due to typical seasonal variations.

Cash payments for employee termination costs and facility exit costs totaled $3 million in the three months ended March 31, 2005. Management expects that cash outlays related to these actions will be substantially completed by the end of 2005. Management intends to fund these cash outlays from existing cash balances and cash flow generated by operations.

On February 28, 2005, the Company’s board of directors declared a special dividend of $31.00 per common which was paid on March 16, 2005. Also, on February 28, 2005, the Company closed on a secured financing consisting of $370 million of term loans and a $60 million revolving credit facility (the “Credit Facilities”). The term loans include a $235 million first lien loan due in March 2011 with an interest rate of LIBOR plus 2.75 percent or base rate plus 1.75 percent, subject to a rate reduction of 0.25 percent if such term loan is rated B1 or better by Moody’s Investor Services, Inc. and a $135 million second lien loan due March 2012 with an interest rate of LIBOR plus 5.75 percent or base rate plus 4.75 percent. The $60 million revolving credit facility matures in March 2010 and carries an interest rate of LIBOR plus 2.75 percent or base rate plus 1.75 percent, subject to rate reductions under a pricing grid if the Company’s leverage ratio decreases. The first lien term loan is subject to amortization of $2.35 million per year for five years, with the remainder payable over the sixth year. There is no amortization over the term of the second lien loan. The Company used approximately $310 million, which is net of $3 million of dividends remaining to be paid, of the financing proceeds to pay the special dividend and $35 million of the proceeds to pre-fund certain defined benefit pension obligations. The remainder of the proceeds were used to pay transaction fees, to refinance existing debt and for general corporate purposes. The Credit Facilities are secured by liens on substantially all of the personal property and certain real property of the Company and its domestic subsidiaries. The Credit Facilities contain covenants which impose certain restrictions on the Company’s ability to, among other things, incur additional debt, pay dividends, make investments or sell assets. Additionally, a portion of excess cash flow, as defined in the Credit Facilities, and certain non-recurring cash inflows such as proceeds from asset sales, insurance recoveries, and equity offerings must be used to pay down indebtedness and may not be reborrowed. In addition, the Credit Facilities contain certain financial covenants which include a maximum leverage ratio, minimum interest coverage ratio and maximum annual capital expenditures. At March 31, 2005, the Company was in compliance with the covenants in the Credit Facilities. In conjunction with securing

 

 

-17-

 



the Credit Facilities, all amounts outstanding under the Company’s then-existing $125 million revolving credit facility were repaid and the underlying credit agreement was terminated.

In April 2005, the Company entered into two no-cost interest rate collar agreements, effectively hedging $185 million of its LIBOR-based floating rate term debt for five years. As a result of entering into the agreements, the interest rate to be paid by the Company relating to the hedged portion of its debt will be based on a minimum three-month LIBOR of 4.05 percent on average and a maximum three-month LIBOR of 5.00 percent.

During the first three months of 2005, the Company contributed $36 million to its pension plan trusts, of which $35 million is in excess of required contribution amounts, and expects to make approximately $1 million of additional required contributions to foreign pension plans during the remainder of the year. Under current assumptions, this accelerated funding is expected to substantially reduce the amount of any cash contributions the Company is required to make during 2006 and 2007.

The Company has not entered into any off-balance financing arrangements.

During the first three months of 2005, the Company made $8 million of capital expenditures and expects to make approximately $25-28 million during the remainder of the year.

Management believes that the Company’s cash flow from operations and availability under its revolving credit facility will be sufficient to cover future debt service requirements, capital expenditures, and working capital requirements during 2005.

Contractual Obligations

In conjunction with securing the Credit Facilities, all amounts outstanding under the Company’s then-existing $125 million revolving credit facility were repaid and the underlying credit agreement was terminated. At December 31, 2004, there was $6,500 outstanding under this facility which was included in the contractual obligations table in the Company’s annual report on Form 10-K under long-term debt, with payments due in 2008. At March 31, 2005, there was $284,000 outstanding under the Credit Facilities, which require payments of $2,350 per year for five years, with the remainder due after 5 years.

Recent Accounting Pronouncements

In December 2004, the FASB issued SFAS No. 123R, “Share-Based Payment (Revised 2004).” This statement addresses the accounting for share-based payment transactions in which a company receives employee services in exchange for the company’s equity instruments or liabilities that are based on the fair value of the company’s equity securities or may be settled by the issuance of these securities. SFAS No. 123R eliminates the ability to account for share-based compensation using the intrinsic value method and generally requires that such transactions be accounted for using a fair value method. In April 2005, the Securities and Exchange Commission adopted a final rule amending the effective date. The provisions of this statement are effective for financial statements issued for the first interim period of the first fiscal year beginning after June 15, 2005. The Company has yet to determine a transition method to adopt SFAS 123R or which valuation method to use. The full impact that the adoption of this statement will have on the Company’s financial statements will be determined by share-based payments granted in future periods, the transition method and valuation model used.

 

 

-18-

 



Item 3.         Quantitative and Qualitative Disclosures About Market Risk.

The Company’s cash flows and earnings are subject to fluctuations resulting from changes in interest rates, foreign currency exchange rates and commodity prices and the Company selectively uses financial instruments to manage these risks. The Company’s objective in managing its exposure to changes in interest rates, foreign currency exchange rates and commodity prices is to reduce volatility on earnings and cash flow associated with such changes. The Company has not entered, and does not intend to enter, into financial instruments for speculation or trading purposes.

The Company measures the market risk related to its holding of financial instruments based on changes in interest rates, foreign currency rates and commodity prices using a sensitivity analysis. The sensitivity analysis measures the potential loss in fair values, cash flows and earnings based on a hypothetical 10 percent change in interest rates, foreign currency exchange rates and commodity prices. The Company used current market rates on its debt and derivative portfolio to perform the sensitivity analysis. Such analysis indicates that a hypothetical 10 percent change in interest rates, foreign currency exchange rates or commodity prices would not have a material impact on the fair values, cash flows or earnings of the Company.

Item 4.         Controls and Procedures.

(a) Disclosure Controls and Procedures. The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures are effective at the reasonable assurance level in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act.

(b) Internal Control Over Financial Reporting. There have not been any changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

 

-19-

 



 

PART II. OTHER INFORMATION

 

Item 1.

 

Legal Proceedings.

 

 

 

 

 

 

 

Richmond Litigation

 

 

 

 

 

 

 

On April 22, 2005 an order was entered substantially granting the Company’s motion to dismiss a majority portion of the original 73,000 proofs of claim so that approximately 25,000 claims remain. Certain Richmond claimants commenced an action in California State Court against, among others, third parties that the Richmond claimants allege to have received fraudulent transfers of the Company’s assets or aided in such transfers. The Company believes that the fraudulent transfer claims and causes of action asserted in the state law complaint are foreclosed by the Company’s Plan of Reorganization and certain Bankruptcy Court orders, including the order confirming the Plan of Reorganization. Accordingly, the Company has recently filed a motion with the Bankruptcy Court, scheduled to be heard May 18, 2005, seeking to enforce the Plan of Reorganization and Bankruptcy Court orders to preclude the continued prosecution of the asserted fraudulent transfer claims.

 

 

 

 

 

Item 2.

 

Unregistered Sales of Equity Securities and Use of Proceeds.

 

 

 

 

 

 

 

NONE

 

 

 

 

 

Item 3.

 

Defaults Upon Senior Securities.

 

 

 

 

 

 

 

NONE

 

 

 

 

 

Item 4.

 

Submission of Matters to a Vote of Security Holders.

 

 

 

 

 

 

 

NONE

 

 

 

 

 

Item 5.

 

Other Information.

 

 

 

 

 

 

 

NONE

 

 

 

 

 

Item 6.

 

Exhibits.

 

 

 

 

 

 

 

Exhibit  No.

 

Description

 

 

 

 

 

 

 

2.1

 

Joint Plan of Reorganization Under Chapter 11, Title 11, United States Code of GenTek Inc., et al., and Noma Company, Debtors, dated August 28, 2003, as filed with the United States Bankruptcy Court for the District of Delaware on August 28, 2003 (incorporated by reference to Exhibit 2.1 of the Registrant’s Form 8-K, filed with the Commission on October 21, 2003).

 

 

 

 

 

 

 

2.2

 

First Modification to Joint Plan of Reorganization Under Chapter 11, Title 11, United States Code of GenTek Inc., et al., and Noma Company, Debtors, dated October 3, 2003 as filed with the United States Bankruptcy Court for the District of Delaware on October 3, 2003 (incorporated by reference to Exhibit 2.2 of the Registrant’s Form 8-K, filed with the Commission on October 21, 2003).

 

 

 

 

 

 

-20-

 



 

 

 

2.3

 

Order confirming Joint Plan of Reorganization Under Chapter 11, Title 11, United States Code of GenTek Inc., et al., and Noma Company, Debtors, as Modified, as entered by the United States Bankruptcy Court for the District of Delaware on October 7, 2003 (incorporated by reference to Exhibit 2.3 of the Registrant’s Form 8-K, filed with the Commission on October 21, 2003).

 

 

 

 

 

 

 

3.1

 

Second Amended and Restated Certificate of Incorporation of GenTek Inc., effective as of November 7, 2003 (incorporated by reference to the Registrant’s Form 8-A to amend its Form 10, dated November 10, 2003, as filed with the Securities and Exchange Commission).

 

 

 

 

 

 

 

3.2

 

Amended and Restated By-Laws of GenTek Inc., effective as of November 10, 2003 (incorporated by reference to the Registrant’s Form 8-A to amend its Form 10, dated November 10, 2003, as filed with the Securities and Exchange Commission).

 

 

 

 

 

 

 

4.1

 

GenTek Inc. Tranche B Warrant Agreement, dated as of November 10, 2003 (incorporated by reference to the Registrant’s Form 8-A to amend its Form 10, dated November 10, 2003, as filed with the Securities and Exchange Commission).

 

 

 

 

 

 

 

4.2

 

GenTek Inc. Tranche C Warrant Agreement, dated as of November 10, 2003 (incorporated by reference to the Registrant’s Form 8-A to amend its Form 10, dated November 10, 2003, as filed with the Securities and Exchange Commission).

 

 

 

 

 

 

 

10.1

 

Form of Registration Rights Agreement by and among the Company and the holders named therein dated as of November 10, 2003 (incorporated by reference to the Registrant’s Form 8-A to amend its Form 10, dated November 10, 2003, as filed with the Securities and Exchange Commission).

 

 

 

 

 

 

 

10.2

 

GenTek Inc. 2003 Management and Directors Incentive Plan (incorporated by reference to the Registrant’s Form 10-Q dated September 30, 2003, as filed with the Securities and Exchange Commission).

 

 

 

 

 

 

 

10.3

 

GenTek Key Employee Retention Plan (incorporated by reference to Exhibit 10.14 to the Registrant’s Form 10-K/A dated April 30, 2003, as filed with the Securities and Exchange Commission).

 

 

 

 

 

 

 

10.4

 

Form of Indemnification Agreement (incorporated by reference to the Registrant’s Form 10-K dated December 31, 2003, as filed with the Securities and Exchange Commission).

 

 

 

 

 

 

 

10.5

 

GenTek Performance Plan (incorporated by reference to the Exhibit 10.3 to the Registrant’s Amendment No. 2 to Form 10, dated April 8, 1999, as filed with the Securities and Exchange Commission).

 

 

 

 

 

 

 

10.6

 

Tax Sharing Agreement between GenTek Inc. and the General Chemical Group Inc. (incorporated by reference to the Exhibit 10.6 to the Registrant’s Amendment No. 2 to Form 10, dated April 8, 1999, as filed with the Securities and Exchange Commission).

 

 

-21-

 



 

 

 

 

 

 

 

 

10.7

 

Share Purchase Agreement by and among ADC Telecommunications Inc., Krone International Holding Inc., Krone Digital Communications Inc., GenTek Holding Corporation, and GenTek Inc., dated March 25, 2004 (incorporated by reference to Exhibit 10.14 of the Registrant’s Form 10-Q for the period ended March 31, 2004, as filed with Securities and Exchange Commission).

 

 

 

 

 

 

 

10.8

 

Employment Agreement with Richard R. Russell (incorporated by reference to the Registrant’s Form 10-Q dated June 30, 2004, as filed with the Securities and Exchange Commission).

 

 

 

 

 

 

 

10.9

 

Amendment to Employment Agreement with Richard R. Russell (incorporated by reference to the Registrant’s Form 10-K dated December 31, 2004, as filed with the Securities and Exchange Commission).

 

 

 

 

 

 

 

10.10

 

Form of Director Restricted Stock Agreement (incorporated by reference to the Registrant’s Form 10-Q dated June 30, 2004, as filed with the Securities and Exchange Commission).

 

 

 

 

 

 

 

10.11

 

Form of Emergence Shares Restricted Stock Agreement (incorporated by reference to the Registrant’s Form 10-Q dated June 30, 2004, as filed with the Securities and Exchange Commission).

 

 

 

 

 

 

 

10.12

 

Form of Restricted Stock Agreement (incorporated by reference to the Registrant’s Form 10-Q dated June 30, 2004, as filed with the Securities and Exchange Commission).

 

 

 

 

 

 

 

10.13

 

Form of Stock Option Agreement (incorporated by reference to the Registrant’s Form 10-Q dated June 30, 2004, as filed with the Securities and Exchange Commission).

 

 

 

 

 

 

 

10.14

 

Form of Performance Cash Award Agreement (incorporated by reference to the Registrant’s Form 10-Q dated June 30, 2004, as filed with the Securities and Exchange Commission).

 

 

 

 

 

 

 

10.15

 

Retention Agreement with Matthew R. Friel (incorporated by reference to the Registrant’s Form 10-Q dated September 30, 2004, as filed with the Securities and Exchange Commission).

 

 

 

 

 

 

 

10.16

 

Form of Letter Agreement and Term Sheet (incorporated by reference to the Registrant’s Form 10-Q dated September 30, 2004, as filed with the Securities and Exchange Commission).

 

 

 

 

 

 

 

10.17

 

Master Settlement Agreement, dated April 30, 2004, among GenTek Holding Corporation, General Chemical LLC, and Honeywell International Inc. (incorporated by reference to the Registrant’s Form 10-Q dated September 30, 2004, as filed with the Securities and Exchange Commission).

 

 

 

 

 

 

 

10.18

 

First Lien Credit and Guaranty Agreement among GenTek, Inc., GenTek Holding LLC, as borrower, the other guarantors party thereto, the lenders party thereto from time to time, Goldman Sachs Credit Partners L.P., as joint lead arranger, General Electric Capital Corporation, as co-administrative agent, and Bank of America, N.A.,

 

 

 

 

 

 

 

-22-

 



 

 

 

 

 

as co-administrative agent and collateral agent, dated February 28, 2005 (incorporated by reference to the Registrant’s Form 10-K dated December 31, 2004, as filed with the Securities and Exchange Commission).

 

 

 

 

 

 

 

10.19

 

Second Lien Credit and Guaranty Agreement among GenTek, Inc., GenTek Holding LLC, as borrower, the other guarantors party thereto, the lenders party thereto from time to time, Goldman Sachs Credit Partners L.P., as joint lead arranger, sole bookrunner, syndication agent, administrative agent and as collateral agent, Bank of America Securities LLC, as joint lead arranger and Bank of America, N.A., as documentation agent, dated February 28, 2005 (incorporated by reference to the Registrant’s Form 10-K dated December 31, 2004, as filed with the Securities and Exchange Commission).

 

 

 

 

 

 

 

31.1

 

Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

31.2

 

Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

32

 

Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002.



 

-23-

 



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned there unto duly authorized.

 



 

 


GENTEK INC.

 

 

 


 

 

 

Registrant

 


Date  May 10, 2005

 

 /s/  


Richard R. Russell

 

 

 


 

 

 

 Richard R. Russell
 President and Chief Executive Officer and Director
 (Principal Executive Officer)

 


Date  May 10, 2005

 

 /s/  


Matthew M. Walsh

 

 

 


 

 

 

 Matthew M. Walsh
 Vice President and Chief Financial Officer
 (Principal Financial and Accounting Officer)

 

-24-